Literature DB >> 6282833

Properties of the src kinase purified from Rous sarcoma virus-induced rat tumors.

N D Richert, D L Blithe, I Pastan.   

Abstract

We recently described a method for the purification of a protein kinase related to pp60src from Rous sarcoma virus-induced rat tumors (Blithe, D. L., Richert, N. D., and Pastan, I. H. (1982) J. Biol. Chem. 257, 7135-7142). In this report, we describe some of the properties of the 7200-fold purified enzyme. The purified kinase phosphorylates casein, vinculin, actin, and histone H2B, but not bovine serum albumin or ovalbumin. Protein substrates are phosphorylated exclusively on tyrosine residues. Casein was used as a substrate for more detailed analysis. The phosphorylation reaction proceeds at a linear rate for at least 40 min at 22 degrees C. Maximum enzyme activity occurs at pH 6.5 to pH 6.8 and requires the presence of either Mg2+ (5 to 10 mM) or Mn2+ (1 to 5 mM). The Km for ATP is 30 microM and the Vmax 0.03 mumol/min/mg using 0.4 mg/ml of casein as a substrate. The enzyme utilizes ATP or dATP, but not GTP as a phosphate donor in the reaction. The enzyme is inhibited by adenosine and deoxyadenosine and by their corresponding mono- and diphosphates. No inhibition of enzyme activity is observed with adenine, GTP, UTP, TTP, or CTP. The enzyme is very sensitive to increased ionic strength. Addition of 0.1 M KCl, 0.1 M NaCl, 50 mM KPO4, or 50 mM NaPO4 inhibited casein phosphorylation by 90 to 95%. Analysis of the products of the phosphorylation reaction by thin layer chromatography revealed that the src kinase phosphorylates glycerol in addition to casein or the enzyme itself.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282833

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.

Authors:  J A Cooper; C S King
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

2.  Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src.

Authors:  P M Coussens; J A Cooper; T Hunter; D Shalloway
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

3.  Alkaline phosphatase and protein kinase(s) activities in free cytoplasmic mRNPs from human term placenta.

Authors:  H Lorberboum; H Galski; C Scharf; D Weinstein; N de Groot; A A Hochberg
Journal:  Mol Biol Rep       Date:  1986       Impact factor: 2.316

Review 4.  Onc genes and other new targets for cancer chemotherapy.

Authors:  H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 5.  Molecular lesions in cancer.

Authors:  H Busch
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

6.  Highly purified pp60src induces the actin transformation in microinjected cells and phosphorylates selected cytoskeletal proteins in vitro.

Authors:  P F Maness; B T Levy
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

7.  Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol.

Authors:  Y Sugimoto; M Whitman; L C Cantley; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis.

Authors:  I G Macara; G V Marinetti; P C Balduzzi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Properties of ATP-dependent protein kinase from Streptococcus pyogenes that phosphorylates a seryl residue in HPr, a phosphocarrier protein of the phosphotransferase system.

Authors:  J Reizer; M J Novotny; W Hengstenberg; M H Saier
Journal:  J Bacteriol       Date:  1984-10       Impact factor: 3.490

10.  Purification and biochemical characterization of non-myristoylated recombinant pp60c-src kinase.

Authors:  N B Lydon; B Gay; H Mett; B Murray; J Liebetanz; A Gutzwiller; H Piwnica-Worms; T M Roberts; E McGlynn
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.